Bösner and colleagues have presented evidence for a simple rule for ruling out coronary
artery disease in the primary care setting. 1 It is noteworthy that no laboratory measurements …

Bösner and colleagues have presented evidence for a simple rule for ruling out coronary
artery disease in the primary care setting. 1 It is noteworthy that no laboratory measurements …

In this issue, Zeller et al. 1 report on the role of detectable cardiac troponin I (cTnI) levels
measured by a high-sensitivity (hs) cTnI assay for prediction of cardiovascular (CV) events …

Cardiac troponin plays an essential role in the diagnosis of myocardial infarction (MI). High-
sensitivity assays for cardiac troponin, which are now in widespread clinical use, improve …

Roche Diagnostics recently issued a technical bulletin calling for an adjustment to the
calibration curve for the Elecsys Troponin T hs and Elecsys Troponin T hs STAT assays …

Cardiac troponin measurements are routinely used for diagnosis and prediction of prognosis
in patients presenting with an acute coronary syndrome. 1–3 Newer highsensitivity assay …

We have read with interest the paper by Collinson et al, 1 and we are grateful for an
opportunity to respond to their comments, especially those that relate to our recent BMJ …

Risk estimates based on classical risk factors only partially explain the incidence of
cardiovascular disease (CVD) in the general population, and risk estimates vary across …

Since high-sensitivity troponin (hsTn) assays became available for clinical use in Europe in
2010, clinicians in the United States have been waiting eagerly for US Food and Drug …

Symptoms suggestive of myocardial infarction (MI) represent one of the most common
conditions in patients presenting to the emergency department. For the diagnostic …